Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr48 Inhibitors

Olfr48, a crucial olfactory receptor, orchestrates the intricate process of odor detection within olfactory sensory neurons, contributing significantly to the nuanced sense of smell. As a G protein-coupled receptor (GPCR), Olfr48 is expressed in these neurons, where it serves as a molecular sensor for specific odorant molecules. Upon activation by odorants, Olfr48 initiates a series of signaling events, leading to the transduction of olfactory signals and eventual perception of distinct smells in the brain. This receptor plays a pivotal role in discerning a wide array of odorants, enabling organisms to navigate and interact with their environments based on olfactory cues. The inhibition of Olfr48 involves a multifaceted interplay with intricate cellular pathways, emphasizing the dynamic nature of its regulation. Direct inhibitors, such as phosphodiesterase inhibitors, disrupt the cyclic AMP (cAMP) signaling cascade, thereby modulating Olfr48 expression indirectly by influencing downstream pathways. Epigenetic modulation through histone deacetylase (HDAC) inhibitors alters the chromatin landscape, impacting the accessibility of Olfr48's promoter region and, consequently, its expression. Furthermore, modulation of key signaling pathways, exemplified by MEK inhibitors affecting the MAPK pathway, indirectly influences Olfr48 expression by altering the phosphorylation state of proteins within the signaling cascade, thereby shaping gene expression.

Calcium channel blockers and PI3K inhibitors also contribute to indirect Olfr48 inhibition by disrupting intracellular calcium levels and affecting the Akt/mTOR pathway, respectively. GPCR antagonists interfere with receptors upstream of Olfr48, modulating signal transduction and inhibiting Olfr48 expression indirectly. Additionally, inhibitors targeting nuclear factor-kappa B (NF-κB), Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway, Wnt pathway, AMP-activated protein kinase (AMPK), toll-like receptors (TLRs), and Notch pathway showcase diverse mechanisms of Olfr48 modulation, each influencing gene expression through distinct cellular processes. This intricate interplay of chemical modulators highlights the regulatory complexity involved in controlling Olfr48 function, providing valuable insights into the molecular mechanisms governing olfactory perception.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$75.00
$212.00
18
(1)

Phosphodiesterase 4 inhibitor disrupting cAMP signaling. Increased cAMP levels alter Olfr48 expression indirectly by modulating downstream pathways.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

HDAC inhibitor impacting chromatin remodeling. Alters the epigenetic landscape, affecting Olfr48 expression by influencing the accessibility of its promoter.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

MEK inhibitor targeting the MAPK pathway. Indirectly inhibits Olfr48 by altering the phosphorylation state of proteins in the signaling cascade, impacting gene expression.

Verapamil

52-53-9sc-507373
1 g
$367.00
(0)

Calcium channel blocker disrupting intracellular calcium levels. Indirectly influences Olfr48 by interfering with calcium-dependent signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor affecting Akt/mTOR pathway. Alters Olfr48 expression indirectly through the modulation of downstream effectors in the PI3K signaling cascade.

Olanzapine

132539-06-1sc-212469
100 mg
$130.00
6
(1)

GPCR antagonist targeting receptors upstream of Olfr48. Modulates signal transduction, indirectly inhibiting Olfr48 expression by interfering with receptor activation.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

NF-κB inhibitor attenuating inflammatory signaling. Indirectly inhibits Olfr48 expression by suppressing NF-κB-mediated transcriptional regulation.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$246.00
$490.00
$536.00
16
(1)

JAK/STAT pathway inhibitor. Modulates Olfr48 expression indirectly by disrupting cytokine signaling through the inhibition of JAK and STAT signaling components.

IWP-2

686770-61-6sc-252928
sc-252928A
5 mg
25 mg
$94.00
$286.00
27
(1)

Wnt pathway antagonist. Indirectly inhibits Olfr48 by interfering with the Wnt signaling cascade, impacting downstream events involved in gene expression.

A-769662

844499-71-4sc-203790
sc-203790A
sc-203790B
sc-203790C
sc-203790D
10 mg
50 mg
100 mg
500 mg
1 g
$180.00
$726.00
$1055.00
$3350.00
$5200.00
23
(2)

AMPK activator influencing energy sensing. Indirectly inhibits Olfr48 by regulating cellular energy status, affecting pathways linked to gene expression.